Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Cancer: Mutations close in on gene regulation.

Aerts S, Cools J.

Nature. 2013 Jul 4;499(7456):35-6. doi: 10.1038/499035a. No abstract available.

PMID:
23823789
2.

RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes.

Greif PA, Konstandin NP, Metzeler KH, Herold T, Pasalic Z, Ksienzyk B, Dufour A, Schneider F, Schneider S, Kakadia PM, Braess J, Sauerland MC, Berdel WE, Büchner T, Woermann BJ, Hiddemann W, Spiekermann K, Bohlander SK.

Haematologica. 2012 Dec;97(12):1909-15. doi: 10.3324/haematol.2012.064667. Epub 2012 Jun 11.

3.

Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.

Hollink IH, van den Heuvel-Eibrink MM, Arentsen-Peters ST, Zimmermann M, Peeters JK, Valk PJ, Balgobind BV, Sonneveld E, Kaspers GJ, de Bont ES, Trka J, Baruchel A, Creutzig U, Pieters R, Reinhardt D, Zwaan CM.

Haematologica. 2011 Mar;96(3):384-92. doi: 10.3324/haematol.2010.031336. Epub 2010 Dec 6.

4.

High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.

Kao HW, Liang DC, Kuo MC, Wu JH, Dunn P, Wang PN, Lin TL, Shih YS, Liang ST, Lin TH, Lai CY, Lin CH, Shih LY.

Oncotarget. 2015 Oct 20;6(32):33217-25. doi: 10.18632/oncotarget.5202.

5.

Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.

Dunlap J, Beadling C, Warrick A, Neff T, Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K, Leeborg N, Gatter K, Braziel RM, Press R, Corless CL, Fan G.

Hum Pathol. 2012 Dec;43(12):2167-76. doi: 10.1016/j.humpath.2012.03.002. Epub 2012 Jun 1.

PMID:
22658276
6.

N-ras mutations in 43 Chinese cases of acute myeloid leukemia.

Guo W, Tang B, Xu S, Yao Y, Ye D.

Chin Med J (Engl). 1998 Apr;111(4):343-5.

PMID:
10374400
7.

Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.

Ahmad F, Rajput S, Mandava S, Das BR.

Genet Test Mol Biomarkers. 2012 Jul;16(7):707-15. doi: 10.1089/gtmb.2011.0317. Epub 2012 Jun 25.

PMID:
22731647
8.

Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype.

Zidan MA, Kamal Shaaban HM, Elghannam DM.

Hematology. 2014 Jul;19(5):267-74. doi: 10.1179/1607845413Y.0000000129. Epub 2013 Nov 25. Erratum in: Hematology. 2015 Apr;20(3):184.

PMID:
24074521
9.

[IDH gene mutations and acute myeloid leukemia].

Sun C, Zhang SJ, Li JY.

Zhonghua Xue Ye Xue Za Zhi. 2013 Mar;34(3):273-5. doi: 10.3760/cma.j.issn.0253-2727.2013.03.023. Review. Chinese. No abstract available.

PMID:
23683434
10.

Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.

Russ AC, Sander S, Lück SC, Lang KM, Bauer M, Rücker FG, Kestler HA, Schlenk RF, Döhner H, Holzmann K, Döhner K, Bullinger L.

Haematologica. 2011 Dec;96(12):1783-91. doi: 10.3324/haematol.2011.046888. Epub 2011 Aug 31.

11.

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

Marcucci G, Maharry K, Radmacher MD, Mrózek K, Vukosavljevic T, Paschka P, Whitman SP, Langer C, Baldus CD, Liu CG, Ruppert AS, Powell BL, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CD.

J Clin Oncol. 2008 Nov 1;26(31):5078-87. doi: 10.1200/JCO.2008.17.5554. Epub 2008 Sep 22. Erratum in: J Clin Oncol. 2008 Dec 20;26(36):6021.

12.

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

Metzeler KH, Maharry K, Radmacher MD, Mrózek K, Margeson D, Becker H, Curfman J, Holland KB, Schwind S, Whitman SP, Wu YZ, Blum W, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD.

J Clin Oncol. 2011 Apr 1;29(10):1373-81. doi: 10.1200/JCO.2010.32.7742. Epub 2011 Feb 22.

13.

IDH mutations in acute myeloid leukemia.

Rakheja D, Konoplev S, Medeiros LJ, Chen W.

Hum Pathol. 2012 Oct;43(10):1541-51. doi: 10.1016/j.humpath.2012.05.003. Epub 2012 Aug 20. Review.

PMID:
22917530
14.

Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.

Pratcorona M, Abbas S, Sanders MA, Koenders JE, Kavelaars FG, Erpelinck-Verschueren CA, Zeilemakers A, Löwenberg B, Valk PJ.

Haematologica. 2012 Mar;97(3):388-92. doi: 10.3324/haematol.2011.051532. Epub 2011 Nov 4.

15.

Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification.

Marcinkowska-Swojak M, Handschuh L, Wojciechowski P, Goralski M, Tomaszewski K, Kazmierczak M, Lewandowski K, Komarnicki M, Blazewicz J, Figlerowicz M, Kozlowski P.

Mutat Res. 2016 Apr;786:14-26. doi: 10.1016/j.mrfmmm.2016.02.001. Epub 2016 Feb 4.

PMID:
26894557
16.

RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.

Kelemen K, Kovacsovics T, Braziel R, Corless C, Beadling C, Fan G.

Leuk Lymphoma. 2012 May;53(5):999-1002. doi: 10.3109/10428194.2011.634047. Epub 2011 Dec 7. No abstract available.

PMID:
22035377
17.

Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia.

Al-Kzayer LF, Sakashita K, Al-Jadiry MF, Al-Hadad SA, Ghali HH, Uyen le TN, Liu T, Matsuda K, Abdulkadhim JM, Al-Shujairi TA, Matti ZI, Sughayer MA, Rihani R, Madanat FF, Inoshita T, Kamata M, Koike K.

Pediatr Blood Cancer. 2015 Dec;62(12):2157-61. doi: 10.1002/pbc.25683. Epub 2015 Jul 29.

PMID:
26222068
18.

Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.

Fried I, Bodner C, Pichler MM, Lind K, Beham-Schmid C, Quehenberger F, Sperr WR, Linkesch W, Sill H, Wölfler A.

Haematologica. 2012 Feb;97(2):246-50. doi: 10.3324/haematol.2011.051581. Epub 2011 Oct 11.

19.

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrózek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind S, Metzeler KH, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Caligiuri MA, Larson RA, Bloomfield CD.

J Clin Oncol. 2010 May 10;28(14):2348-55. doi: 10.1200/JCO.2009.27.3730. Epub 2010 Apr 5.

20.

Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.

Elghannam DM, Abousamra NK, Shahin DA, Goda EF, Azzam H, Azmy E, El-Din MS, El-Refaei MF.

Egypt J Immunol. 2009;16(1):9-15.

PMID:
20726318

Supplemental Content

Support Center